KEYNOTE

Wednesday, July 14, 2021

Transpacific Collaboration of Healthcare Business Between Japan and US

Fumiaki Ikeno, MD
Program Director (U.S.)

Japan Biodesign

Stanford Biodesign

Dr. Ikeno is a Researcher, Cardiovascular Medicine, Stanford University. In this role, オンライン ブラック ジャックs responsible for pre clinical studies including GLP for medical devices and also regenerative medicines for cardiovascular diseases. Currently, オンライン ブラック ジャックs devoting himself to tオンライン ブラック ジャックnternational regulatory project between Japan and the United States, also known as "Harmonization by Doing", whose focus is to collaborate with regulatory agencies such as FDA, PMDA/MHLW, academia and industries for improving the regulatory process in the 2 largest medtech markets. Dr. Ikeno also devoted himself to found Japan biodesign program which is a collaborative program with University of Tokyo, Osaka University, Tohoku University, Japan Federation Medical Device Association, Ministry of Education Japan and Stanford biodesign program. Currently, Dr. Ikeno serves as the Program Director (US) for Japan Biodesign. Dr. Ikeno is co-founder and board member of US-Japan MedTech Frontier which is a non-profit cooperate to make a trans-pacific eco-system of medical device between Japan and USA.

After 9 years clinical practice オンライン ブラック ジャックn interventional cardiologist and Family Doctor in rural areas of Japan, Dr. Ikeno came to Stanford オンライン ブラック ジャック Researcher and completed his Biodesign Certificate Program. Being part of the ecosystem in Silicon Valley, Dr. Ikeno participated in more than 200 medtech projects and 50 GLP studies as well as in the analysis of clinical trials for cardiovascular medicine (BARI2D, FAME, ReOPEN etc.). His other academic consortium projects include Peripheral Academic Research Consortium, Global Consensus Working Group of Optical Coherence Tomography, and Japan-US consensus document for the treatment of critical limb ischemia.

Over the last decade, Dr. Ikeno has served as an advisor for medical device industries and currently serves as a chief medical officer of an incubation fund specific for medtech (Medventure Partners, Inc, Tokyo) as a spin-off from Innovation Network Corporation of Japan (INCJ) that is the largest government and private partnership fund in Japan. オンライン ブラック ジャックs also serving as a chair of cardiovascular working group of APAN (Asian Pacific Advanced Network) that contributes the remote education, research activities, and tele-health using a specialized internet network. Dr. Ikeno is also serving as consulting faculty/lecturer roles in several universities in Japan including University of Tokyo, Osaka University, Tsukuba University etc. Dr. Ikeno has authored over 70 peer reviewed publications and textbooks and has been invited to lecture at international medical conferences. Dr. Ikeno is a council member of U.S.- Japan Council which is a non-profit organization by Japanese American. オンライン ブラック ジャックs serving as a mentor for START-X MED which is an accelerating program for Stanford related entrepreneurs in medical fields.